de Bruijn, Winnie ;
Ibáñez, Cristina ;
Frisk, Pia...
de Bruijn , W , Ibáñez , C , Frisk , P , Bak Pedersen , H , Alkan , A , Vella Bonanno , P , Brkicic , L S , Bucsics , A , Dedet , G , Eriksen , J , Fadare , J O , Fürst , J , Gallego , G , Godói , I P , Guerra Júnior , A A , Gürsöz , H , Jan , S , Jones , J , Joppi , R , Kerman , S , Laius , O , Madzikwa , N , Magnússon , E , Maticic , M , Markovic-Pekovic , V , Massele , A , Ogunleye , O , O'Leary , A , Piessnegger , J , Sermet , C , Simoens , S , Tiroyakgosi , C , Truter , I , Thyberg , M , Tomekova , K , Wladysiuk , M , Vandoros , S , Vural , E H , Zara , C & Godman , B 2016 , ' Introduction and utilization of high priced HCV medicines across Europe; implications for the future ' , Frontiers in Pharmacology , vol. 7 , no. JUL , 197 . https://doi.org/10.3389/fphar.2016.00197.
,
2016
